Skip to main content
Top
Published in: Journal of Cancer Education 4/2010

01-12-2010

Steven Woloshin, Lisa M. Schwartz, H. Gilbert Welch: Know Your Chances: Understanding Heath Statistics

142 pages. Berkeley: University of California Press; 2008. $16.95. ISBN-13: 978-0-5202-5222-6

Author: Brian P. Lucas

Published in: Journal of Cancer Education | Issue 4/2010

Login to get access

Excerpt

This is a math-friendly primer of numeracy that trains patients to “know the outcome; get the numbers!” Potential consumers of the primer can, rather unusually, review experimental evidence about its efficacy before they buy it, because the authors compared an earlier version of the primer to a generic, control booklet in two randomized trials [1]. The control booklet was similar in length and reading level, but unlike the primer, it did not include training on how to interpret numbers. Given the current state of numeracy, however, a potential consumer may not be able to meaningfully translate the trials’ numbers into a value-driven decision about whether or not to buy Know Your Chances. Therefore, I will apply the self-study curriculum from Know Your Chances to interpret the results of these trials and, in doing so, make full use of this unusual circumstance. …
Literature
1.
go back to reference Woloshin S, Schwartz LM, Gilbert Welch H (2007) The effectiveness of a primer to help people understand risk. Ann Intern Med 146:256–265PubMed Woloshin S, Schwartz LM, Gilbert Welch H (2007) The effectiveness of a primer to help people understand risk. Ann Intern Med 146:256–265PubMed
Metadata
Title
Steven Woloshin, Lisa M. Schwartz, H. Gilbert Welch: Know Your Chances: Understanding Heath Statistics
142 pages. Berkeley: University of California Press; 2008. $16.95. ISBN-13: 978-0-5202-5222-6
Author
Brian P. Lucas
Publication date
01-12-2010
Publisher
Springer-Verlag
Published in
Journal of Cancer Education / Issue 4/2010
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-010-0124-8

Other articles of this Issue 4/2010

Journal of Cancer Education 4/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine